Clinical Trial Update: Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of a plague vaccine (Flagellin/F1/V) in healthy adult volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plague

Drugs mentioned

• Flagellin/F1/V plague vaccine (Flagellin/F1/V)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plague | Phase 1 | Status: COMPLETED